JSP-W1-R Stock Financial Analysis - JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd.

Quality, Value, Momentum Scores

This card shows the Quality, Value, and Momentum scores for the company

Quality

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Value

Proprietary scoring model that ranks companies based on their relative valuation. Scores range from 0 to 100, with 100 being the most undervalued.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Fund Sentiment

The Fund Sentiment (fka Ownership) score is a proprietary quantitative model that ranks companies based on levels of ownership accumulation.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Income Statement: Revenue, Operating Income, Net Income

The revenue for JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. - Equity Right as of June 30, 2025 is 984.27 MM.
The operating income for JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. - Equity Right as of June 30, 2025 is 132.50 MM.
The net income for JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. - Equity Right as of June 30, 2025 is 28.43 MM.

Period End (TTM)	Revenue (MM)	Operating Income (MM)	Net Income (MM)
2025-06-30	984.27	132.50	28.43
2025-03-31	918.42	116.01	14.48
2024-12-31	845.93	102.35	4.52
2024-09-30	769.05	81.10	51.16
2024-06-30	702.51	37.65	21.50
2024-03-31	627.73	-0.10	-6.04
2023-12-31	594.36	-0.41	-1.72
2023-09-30	585.42	12.94	2.49
2023-06-30	518.35	4.59	-5.56
2023-03-31	505.58	12.15	-4.04
2022-12-31	466.80	-1.07	-17.48
2022-09-30	419.14	-15.75	-24.14
2022-06-30	418.64	0.28	-13.11
2022-03-31	418.84	23.74	10.63
2021-12-31	429.13	48.30	29.69
2021-09-30	422.41	52.64	32.05
2021-06-30	421.18	53.04	31.85
2021-03-31	432.95	50.15	29.26
2020-12-31	462.74	53.12	31.08

Income Statement: EPS

Period End (TTM)	Earnings Per Share Basic	Earnings Per Share Diluted
2025-06-30
2025-03-31
2024-12-31	0.01	0.01
2024-09-30	0.11	0.11
2024-06-30	0.05	0.04
2024-03-31	-0.01	-0.01
2023-12-31	-0.00
2023-09-30	0.01	0.00
2023-06-30	-0.01	-0.02
2023-03-31	-0.01	-0.01
2022-12-31	-0.04	-0.04
2022-09-30	-0.05	-0.06
2022-06-30	-0.03	-0.03
2022-03-31	0.03	0.02
2021-12-31	0.08	0.08
2021-09-30	0.09	0.10
2021-06-30	0.10	0.10
2021-03-31	0.08	0.08
2020-12-31	0.09

Cash Flow: Operations, Investing, Financing

The cash from operating activities for JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. - Equity Right as of June 30, 2025 is 127.54 MM.
The cash from investing activities for JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. - Equity Right as of June 30, 2025 is -43.84 MM.
The cash from financing activities for JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. - Equity Right as of June 30, 2025 is -78.90 MM.

Period End (TTM)	Cash From Operating Activities (MM)	Cash From Investing Activities (MM)	Cash From Financing Activities (MM)
2025-06-30	127.54	-43.84	-78.90
2025-03-31	132.93	-46.13	-84.80
2024-12-31	132.12	-56.64	-66.64
2024-09-30	118.32	-74.02	-32.22
2024-06-30	77.13	-132.81	21.33
2024-03-31	44.35	-152.02	20.43
2023-12-31	40.35	-202.49	82.60
2023-09-30	39.03	-139.68	73.99
2023-06-30	49.00	-136.57	14.79
2023-03-31	68.62	-330.99	21.72
2022-12-31	2.81	-463.90	-64.61
2022-09-30	-17.71	-543.38	616.92
2022-06-30	-19.55	-472.58	629.46
2022-03-31	-1.62	-253.84	615.17
2021-12-31	51.72	-58.26	629.95
2021-09-30	77.99	-14.19	-58.21
2021-06-30	61.50	-10.71	-53.78
2021-03-31	46.83	-6.91	-41.11
2020-12-31	45.99	-1.53	-44.10

Valuation Metrics : PE, PriceToBook, PriceToTBV

P/Book: The current closing price divided by the book value per share.

P/TBV: The current price divided by the tangible book value per share.

Period End (TTM)	p/e	P/Book	P/TBV
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31

Valuation Metrics : EBitToEv, EBit3YrAvgToEv

Period End (TTM)	EBIT/EV	EBIT (3y)/EV
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31

Management Effectiveness

The roa for JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. - Equity Right as of June 30, 2025 is -0.00.
The roe for JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. - Equity Right as of June 30, 2025 is -0.00.
The roic for JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. - Equity Right as of June 30, 2025 is -0.00.
The croic for JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. - Equity Right as of June 30, 2025 is -0.07.
The ocroic for JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. - Equity Right as of June 30, 2025 is 0.03.

Period End (TTM)	ROA	ROE	ROIC	CROIC	OCROIC
2025-06-30	-0.00	-0.00	-0.00	-0.07	0.03
2025-03-31	-0.00	-0.00	-0.00	-0.07	0.03
2024-12-31	-0.00	-0.00	-0.00	-0.07	0.03
2024-09-30	-0.00	-0.00	-0.00	-0.07	0.03
2024-06-30	-0.00	-0.00	-0.00	-0.07	0.03
2024-03-31	-0.00	-0.00	-0.00	-0.07	0.03
2023-12-31	0.00	0.00	0.00	-0.02	0.03
2023-09-30	-0.00	-0.01	-0.00	-0.06	0.03
2023-06-30	-0.00	-0.01	-0.00	-0.06	0.03
2023-03-31	-0.00	-0.00	-0.00	-0.21	0.05
2022-12-31	-0.04	-0.13	-0.02	0.05	-0.02
2022-09-30	-0.04	-0.13	-0.02	0.05	-0.02
2022-06-30	-0.02	-0.06	-0.01	0.12	-0.02
2022-03-31	0.02	0.05	0.01	0.32	-0.00
2021-12-31	0.06	0.15	0.02	0.52	0.04
2021-09-30		0.19	0.07	0.01	0.17
2021-06-30	0.07	0.19	0.07	-0.01	0.13
2021-03-31	0.07	0.18	0.07	-0.00	0.12
2020-12-31	0.07	0.19	0.08	0.00	0.11

Gross Margins

The gross margin for JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. - Equity Right as of June 30, 2025 is 0.27.
The net margin for JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. - Equity Right as of June 30, 2025 is -0.00.
The operating margin for JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. - Equity Right as of June 30, 2025 is 0.00.

Gross Margin: The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.

Net Margin: The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.

Operating Margin: The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.

Period End (TTM)	Gross Margin	Net Margin	Operating Margin
2025-06-30	0.27	-0.00	0.00
2025-03-31	0.27	-0.00	0.00
2024-12-31	0.27	-0.00	0.00
2024-09-30	0.27	-0.00	0.00
2024-06-30	0.27	-0.00	0.00
2024-03-31	0.27	-0.00	0.00
2023-12-31	0.26	0.00	-0.00
2023-09-30	0.28	-0.01	0.00
2023-06-30	0.28	-0.01	0.00
2023-03-31	0.30	-0.01	0.00
2022-12-31	0.30	-0.06	-0.06
2022-09-30	0.30	-0.06	-0.06
2022-06-30	0.31	-0.03	-0.02
2022-03-31	0.34	0.03	0.06
2021-12-31	0.35	0.07	0.11
2021-09-30	0.35	0.08	0.12
2021-06-30	0.35	0.08	0.13
2021-03-31	0.34	0.07	0.12
2020-12-31	0.33	0.07	0.11

JSP-W1-R Stock Financial Analysis - JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. - Equity Right (SET) Stock